We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+5.02%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$1.05B
AUM Growth
+$9.85M
Cap. Flow
+$95.1M
Cap. Flow %
9.1%
Top 10 Hldgs %
50%
Holding
874
New
223
Increased
214
Reduced
73
Closed
220

Sector Composition

Rank Sector Weight
1 Healthcare 34.11%
2 Financials 8.03%
3 Materials 6.97%
4 Technology 3.58%
5 Industrials 3.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENTG icon
51
Entegris
ENTG
$22B
$1.93M 0.18%
+229,700
New +$22.4M
AMD icon
52
Advanced Micro Devices
AMD
$767B
$1.9M 0.18%
+30,000
New +$2.55M
CND
53
DELISTED
Concord Acquisition Corp.
CND
$1.83M 0.18%
186,498
BWAC
54
DELISTED
BETTER WORLD ACQUISITION CORP. Common Stock
BWAC
$1.67M 0.16%
160,991
-389,009
-71% -$4.03M
WFC icon
55
Wells Fargo
WFC
$265B
$1.62M 0.15%
114,954
+81,964
+248% +$3.52M
INVZW
56
DELISTED
Innoviz Technologies Warrant
INVZW
$1.59M 0.15%
721,715
TEVA icon
57
Teva Pharmaceuticals
TEVA
$42.1B
$1.54M 0.15%
453,800
+295,716
+187% +$2.61M
KRE icon
58
State Street SPDR S&P Regional Banking ETF
KRE
$4.56B
$1.5M 0.14%
123,700
+104,556
+546% +$6.54M
CHNG
59
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$1.5M 0.14%
+54,500
New +$1.35M
FHN icon
60
First Horizon
FHN
$12B
$1.49M 0.14%
90,256
+18,242
+25% +$415K
PYPL icon
61
PayPal
PYPL
$50.5B
$1.44M 0.14%
+16,708
New +$1.48M
WBD icon
62
Warner Bros
WBD
$67.4B
$1.41M 0.13%
122,200
-100,000
-45% -$1.36M
LMACU
63
DELISTED
Liberty Media Acquisition Corporation Unit
LMACU
$1.38M 0.13%
+138,433
New +$1.37M
COIN icon
64
Coinbase
COIN
$39.2B
$1.32M 0.13%
+20,505
New +$1.43M
ROSS
65
DELISTED
Ross Acquisition Corp II
ROSS
$1.13M 0.11%
+113,871
New +$1.12M
MUFG icon
66
Mitsubishi UFJ Financial
MUFG
$251B
$1.13M 0.11%
+250,000
New +$1.3M
RNW icon
67
ReNew
RNW
$2.23B
$1.12M 0.11%
+186,568
New +$1.27M
SJR
68
DELISTED
Shaw Communications Inc.
SJR
$1.12M 0.11%
+46,015
New +$1.22M
LNZA icon
69
LanzaTech
LNZA
$70.1M
$1.08M 0.1%
+1,103
New +$1.09M
BYND icon
70
Beyond Meat
BYND
$268M
$1.06M 0.1%
+75,000
New +$2.07M
LQD icon
71
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.6B
$1.02M 0.1%
+10,000
New +$1.1M
BIIB icon
72
Biogen
BIIB
$30.6B
$1.01M 0.1%
10,925
+9,389
+611% +$1.99M
IPOF.U
73
DELISTED
Social Capital Hedosophia Holdings Corp. VI Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
IPOF.U
$1M 0.1%
+100,300
New +$1.01M
BMY icon
74
Bristol-Myers Squibb
BMY
$132B
$999K 0.1%
14,059
+9,005
+178% +$653K
ACQR
75
DELISTED
Independence Holdings Corp. Class A Ordinary Share
ACQR
$992K 0.09%
+100,000
New +$986K

Similar funds

Cowen and Company's Q3 2022 Portfolio in Review

As of Q3 2022, Cowen and Company held 874 positions worth $1.05B, up 0.95% from $1.04B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Cowen and Company deployed $95.1M of net new capital in Q3 2022, opening 223 new positions and adding to 214 existing holdings. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 726,608 shares worth $20.8M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 29% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was Relmada Therapeutics, an estimated $23.6M trimmed.

  • Cowen and Company's largest Q3 2022 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 726,608 shares worth $20.8M.
  • Cowen and Company added most to ARK Innovation ETF in Q3 2022, an estimated $41.6M increase.
  • Cowen and Company's biggest Q3 2022 reduction was Relmada Therapeutics, cutting an estimated $23.6M.
  • Cowen and Company fully exited Pershing Square Tontine Holdings, Ltd. in Q3 2022, selling an estimated $19M.
  • Cowen and Company's ten largest holdings make up 50% of its $1.05B portfolio in Q3 2022.
  • Cowen and Company opened 223 new positions and closed 220 in Q3 2022.
  • Cowen and Company's portfolio value rose 0.95% quarter-over-quarter to $1.05B.

Based on Cowen and Company's 13F filing for Q3 2022, filed 14 Nov 2022.